{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:27:17Z","timestamp":1793600837959,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.neuropharm.2026.110952","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:14:13Z","timestamp":1774628053000},"page":"110952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effects of acute fluctuations of extracellular Zinc on network activity of human iPSC-derived neurons; impact of NMDA Receptor and L-Type Calcium Channel Activation"],"prefix":"10.1016","volume":"292","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8276-8854","authenticated-orcid":false,"given":"Mouhamed","family":"Alsaqati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-813X","authenticated-orcid":false,"given":"Josephine E.","family":"Haddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0403-3278","authenticated-orcid":false,"given":"Jeremy","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-5169","authenticated-orcid":false,"given":"Adrian J.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9337-6124","authenticated-orcid":false,"given":"Lawrence S.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41398-022-02199-z","article-title":"NRSF\/REST lies at the intersection between epigenetic regulation, miRNA-mediated gene control and neurodevelopmental pathways associated with intellectual disability (ID) and schizophrenia","volume":"12","author":"Alsaqati","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13229-020-00391-w","article-title":"Pharmacological intervention to restore connectivity deficits of neuronal networks derived from ASD patient iPSC with a TSC2 mutation","volume":"11","author":"Alsaqati","year":"2020","journal-title":"Mol. Autism"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110952_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/syn.20683","article-title":"Zn2+: the brain's dark horse","volume":"63","author":"Bitanihirwe","year":"2009","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110952_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nbt.1529","article-title":"Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signalling","volume":"27","author":"Chambers","year":"2009","journal-title":"Nat. Biotechnol."},{"issue":"20","key":"10.1016\/j.neuropharm.2026.110952_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.168440","article-title":"Neuronal SLC39A8 deficiency impairs cerebellar development by altering manganese homeostasis","volume":"9","author":"Choi","year":"2024","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110952_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.57","article-title":"New therapeutic targets in alzheimer's disease: brain deregulation of calcium and Zn2+","volume":"2","author":"Corona","year":"2011","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2026.110952_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9812178","article-title":"Metals and neuronal metal binding proteins implicated in alzheimer's disease","author":"Crist\u00f3v\u00e3o","year":"2016","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.neuropharm.2026.110952_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.974890","article-title":"More than a marker: potential pathogenic functions of MAP2","volume":"15","author":"DeGiosio","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41398-021-01549-7","article-title":"Alteration of NMDA receptor trafficking as a cellular hallmark of psychosis","volume":"11","author":"Espana","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110952_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0896-6273(00)81070-3","article-title":"Four residues of the extracellular N-terminal domain of the NR2A subunit control high-affinity Zn2+ binding to NMDA receptors","volume":"25","author":"Fayyazuddin","year":"2000","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1113\/jphysiol.2013.261420","article-title":"Endogenous Zn2+ depresses GABAergic transmission via T-type Ca(2+) channels and broadens the time window for integration of glutamatergic inputs in dentate granule cells","volume":"592","author":"Grauert","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2026.110952_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neures.2016.09.001","article-title":"Synapse pathology and translational applications for schizophrenia","volume":"114","author":"Hayashi-Takagi","year":"2017","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2026.110952_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.schres.2016.07.006","article-title":"Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia","volume":"176","author":"Hess","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/nyas.12547","article-title":"The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies","volume":"1338","author":"Hu","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110952_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/jnr.490330402","article-title":"The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration","volume":"33","author":"Johnson","year":"1992","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110952_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","article-title":"From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms","volume":"14","author":"Kabir","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2026.110952_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100320","article-title":"Zn2+ transporters and their functional integration in mammalian cells","volume":"296","author":"Kambe","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110952_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072570","article-title":"Carnosine as a possible drug for zinc-induced neurotoxicity and vascular dementia","volume":"21","author":"Kawahara","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0306-4522(98)00313-3","article-title":"zinc-induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals","volume":"89","author":"Kim","year":"1999","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110952_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/15384101.2016.1234550","article-title":"Gene length as a biological timer to establish temporal transcriptional regulation","volume":"16","author":"Kirkconnell","year":"2017","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110952_bib23","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1073\/pnas.092034699","article-title":"Contribution by synaptic Zn2+ to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41398-022-02137-z","article-title":"The schizophrenia-associated missense variant rs13107325 regulates dendritic spine density","volume":"12","author":"Li","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12881-020-01084-0","article-title":"The genome-wide supported CACNA1C gene polymorphisms and the risk of schizophrenia: an updated meta-analysis","volume":"21","author":"Liu","year":"2020","journal-title":"BMC Med. Genet."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110952_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"20","key":"10.1016\/j.neuropharm.2026.110952_bib27","doi-asserted-by":"crossref","first-page":"11062","DOI":"10.1073\/pnas.180307497","article-title":"Molecular determinants of coordinated proton and Zn2+ inhibition of N-methyl-D-aspartate NR1\/NR2A receptors","volume":"97","author":"Low","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110952_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.neubiorev.2017.06.006","article-title":"Zn2+ transporter 3 (ZnT3) and vesicular Zn2+ in central nervous system function","volume":"80","author":"McAllister","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110952_bib29","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/schbul\/sby096","article-title":"CACNA1C: association with psychiatric disorders, behavior, and neurogenesis","volume":"44","author":"Moon","year":"2018","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2026.110952_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2020.107230","article-title":"The role of L-type calcium channels in neuronal excitability and aging","volume":"173","author":"Moore","year":"2020","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2026.110952_bib31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-3-319-60189-2_15","article-title":"Neurotoxicity of Zn2+","volume":"18","author":"Morris","year":"2017","journal-title":"Adv Neurobiol"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110952_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.brainresrev.2008.10.003","article-title":"Zn2+ and cortical plasticity","volume":"59","author":"Nakashima","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib33","first-page":"38","article-title":"An effective freezing\/thawing method for human pluripotent stem cells cultured in chemically-defined and feeder-free conditions","volume":"4","author":"Nishishita","year":"2015","journal-title":"Am J Stem Cells"},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110952_bib35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.biopsych.2007.10.020","article-title":"Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia","volume":"63","author":"Oni-Orisan","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"15","key":"10.1016\/j.neuropharm.2026.110952_bib36","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1523\/JNEUROSCI.17-15-05711.1997","article-title":"High-affinity Zn2+ inhibition of NMDA NR1-NR2A receptors","volume":"17","author":"Paoletti","year":"1997","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110952_bib37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0896-6273(00)00163-X","article-title":"Molecular organization of a Zn2+ binding N-Terminal modulatory domain in a NMDA receptor subunit","volume":"28","author":"Paoletti","year":"2000","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110952_bib38","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.neuro.2006.11.006","article-title":"Quantification of Zn2+ toxicity using neuronal networks on microelectrode arrays","volume":"28","author":"Parviz","year":"2007","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50226-9","article-title":"L-type voltage-gated calcium channel regulation of in vitro human cortical neuronal networks","volume":"9","author":"Plumbly","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2026.110952_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/591563","article-title":"Relationship between Zn (Zn (2+)) and glutamate receptors in the processes underlying neurodegeneration","volume":"2015","author":"Pochwat","year":"2015","journal-title":"Neural Plast."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110952_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1074\/jbc.M115.663468","article-title":"Zn2+-dependent activation of the trk signalling pathway induces phosphorylation of the brain-enriched tyrosine phosphatase STEP: molecular basis for ZN2+-INDUCED ERK mapk activation","volume":"291","author":"Poddar","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110952_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122506","article-title":"Zn2+ signal in brain diseases","volume":"18","author":"Portbury","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.neuropharm.2026.110952_bib43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1162\/089976604774201631","article-title":"Unsupervised spike detection and sorting with wavelets and superparamagnetic clustering","volume":"16","author":"Quiroga","year":"2004","journal-title":"Neural Comput."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110952_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081031","article-title":"Stimulation of GABA-induced Ca2+ influx enhances maturation of human induced pluripotent stem cell-derived neurons","volume":"8","author":"Rushton","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110952_bib45","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.schres.2009.08.003","article-title":"Resequencing and association study of vesicular glutamate transporter 1 gene (VGLUT1) with schizophrenia","volume":"115","author":"Shen","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuropharm.2026.110952_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.b.33037","article-title":"SLC39A8.p.(Ala391Thr) is associated with poorer cognitive ability: a cross-sectional study of schizophrenia and the general UK population","author":"Smart","year":"2025","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics. Part B: 0:e33037"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110952_bib47","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/s41380-020-01001-0","article-title":"Neurotrophin receptor activation rescues cognitive and synaptic abnormalities caused by hemizygosity of the psychiatric risk gene Cacna1c","volume":"26","author":"Tigaret","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110952_bib48","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41398-021-01262-5","article-title":"Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signalling","volume":"11","author":"Tseng","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110952_bib49","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.neuron.2014.04.034","article-title":"Zn2+ dynamics and action at excitatory synapses","volume":"82","author":"Vergnano","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2026.110952_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.111","article-title":"Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients","volume":"4","author":"Wockner","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110952_bib51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.str.2018.05.004","article-title":"Glutamate and glycine binding to the NMDA receptor","volume":"26","author":"Yu","year":"2018","journal-title":"Structure"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110952_bib52","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1210\/en.2015-1899","article-title":"Spontaneous and CRH-Induced excitability and calcium signaling in mice corticotrophs involves sodium, calcium, and cation-conducting channels","volume":"157","author":"Zemkova","year":"2016","journal-title":"Endocrinology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:35:41Z","timestamp":1793597741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":49,"alternative-id":["S0028390826001255"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110952","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of acute fluctuations of extracellular Zinc on network activity of human iPSC-derived neurons; impact of NMDA Receptor and L-Type Calcium Channel Activation","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110952"}}